Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sigyn Therapeutics ( (SIGY) ) has provided an update.
On January 11, 2025, Sigyn Therapeutics appointed Michael Ryan to their Board of Directors. Mr. Ryan brings extensive experience in the early-stage technology and life science industry, having co-founded Irrus Investments, Ireland’s largest angel investment syndicate focusing on life science companies. This strategic appointment underscores Sigyn Therapeutics’ commitment to enhancing its leadership team with experienced professionals, potentially strengthening its market position and future growth prospects.
More about Sigyn Therapeutics
YTD Price Performance: 21.43%
Average Trading Volume: 252
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.06M
For detailed information about SIGY stock, go to TipRanks’ Stock Analysis page.